Is Rigel Pharmaceuticals, Inc. (RIGL) Stock a Bad Value Monday?

Rigel Pharmaceuticals, Inc. (RIGL) is near the bottom in its sector according to InvestorsObserver. RIGL gets an overall rating of 15. That means it scores higher than 15% of stocks. Rigel Pharmaceuticals, Inc. gets a 22 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

RIGL has an Overall Score of 15. Find out what this means to you and get the rest of the rankings on RIGL!

See Full RIGL Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 15 would rank higher than 15 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Rigel Pharmaceuticals, Inc. Stock Today?

Rigel Pharmaceuticals, Inc. (RIGL) stock is lower by -2.14% while the S&P 500 is higher by 0.94% as of 10:01 AM on Monday, Aug 8. RIGL is down -$0.03 from the previous closing price of $1.52 on volume of 244,232 shares. Over the past year the S&P 500 is down -5.60% while RIGL is down -61.10%. RIGL lost -$0.49 per share the over the last 12 months. Click Here to get the full Stock Report for Rigel Pharmaceuticals, Inc. stock.